<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04043715</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY00004478</org_study_id>
    <secondary_id>EEC-1028725</secondary_id>
    <nct_id>NCT04043715</nct_id>
  </id_info>
  <brief_title>Comparison of Transcutaneous and Epidural Spinal Stimulation for Improving Function</brief_title>
  <official_title>Spinal Stimulation for Standing &amp; Walking; Comparison of Transcutaneous &amp; Epidural Stimulation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>U.S. National Science Foundation</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Washington</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Incomplete spinal cord injuries (SCI) are the most frequent neurologic category, comprising
      66.7% of all SCI cases. People with incomplete SCI may retain some ability to move the legs
      and therefore the capacity to regain walking. Studies that show functional improvement in
      locomotion via electrical stimulation of lumbosacral circuits suggest that the underlying
      mechanisms are neuromodulation of lumbosacral spinal cord automaticity and sensory feedback.

      Both epidural and transcutaneous spinal stimulation are demonstrating exciting potential to
      improve limb function for people after chronic SCI. Available treatment options for SCI are
      less than satisfactory and most often do not achieve full restoration of function. Recent
      experimental results suggest an exciting new approach of using electrical spinal stimulation
      to enable users to regain control of their weak or paralyzed muscles. Using
      surgically-implanted electrodes, epidural stimulation results in remarkable improvements of
      lower extremity function as well as autonomic functions such as bladder function and sexual
      function.

      In addition to epidural stimulation, over only the last few years a novel strategy of skin
      surface electrical spinal stimulation has also demonstrated exciting potential for improving
      walking function. Using a high-frequency stimulation pulse, current can pass through the skin
      without discomfort and activate the spinal cord; this results in patterned stepping movements
      for people without SCI and improved lower extremity function following SCI. This study will
      directly compare skin-surface transcutaneous stimulation with implanted epidural stimulation
      for improving lower extremity function.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to determine the optimal method for delivering spinal
      stimulation to improve walking in people with incomplete spinal cord injury. By directly
      comparing non-invasive transcutaneous (TransQ) stimulation with implanted epidural
      stimulation, investigators hope to guide the field toward the most beneficial method for
      restoration of lower extremity function. In addition, the investigators may identify
      subgroups of people that respond better to each type of stimulation, informing personalized
      treatment for people with different types of spinal cord injury. The research team will
      explore the following specific aims:

      Aim 1: Evaluate the improvements in lower extremity and autonomic function via transcutaneous
      spinal stimulation and intensive physical therapy for people with chronic SCI.

      Aim 2: Quantify additional improvements in lower extremity and autonomic function via
      epidural spinal stimulation and intensive physical therapy for people with chronic SCI.

      The investigators will test the hypothesis that epidural stimulation leads to greater
      improvements than an equal dose of transcutaneous stimulation. To compare these 2 stimulation
      methods the study team will evaluate voluntary control of muscle activity via EMG and
      kinematic parameters of locomotion, as well as improvements in bladder and other autonomic
      functions and overall quality of life.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>This study will compare the benefits of transcutaneous and epidural stimulation in individuals with SCI through a phased intervention program including: 1) baseline testing, 2) PT only, 3) PT + TransQ stimulation, 4) wash out/recovery, 5) PT + Epidural stimulation, 6) follow-up testing.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Neuromuscular Recovery Scale</measure>
    <time_frame>8-11 months</time_frame>
    <description>Neuromuscular recovery scale is an assessment for sitting, standing and walking functions based on a comparison to pre-injury performance criteria or how a task was performed one day prior to spinal cord injury and without use of compensation strategies. The items consists of stand retraining, stand adaptability, step retraining, step adaptability, sit, reverse sit up, trunk extension in sitting, sit to stand , stand, walking, and upper limb functions. They are score the scale of 4 based on how close to the function in the pre-injured condition.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) Examination</measure>
    <time_frame>8-11 months</time_frame>
    <description>Standard neurologic examination that is routinely used to determine the levels and severity of spinal cord injury. Includes manual muscle strength testing and dermatomal light touch and pin prick sensory examination.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Somatosensory evoked potentials</measure>
    <time_frame>8-11 months</time_frame>
    <description>Measurement of amplitude of electrical potentials that is recorded by surface electrodes over the scalp following electrical stimulation of peripheral nerve from the wrist. The amplitude of the response is reported in micro-volts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor evoked potentials - Latency</measure>
    <time_frame>8-11 months</time_frame>
    <description>Measurement of latency of electrical potentials that is recorded by surface electrodes over the skin of limb muscles following spinal stimulation or magnetic stimulation of brain over the scalp. The latency of the response is reported in micro-seconds.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Motor evoked potentials - Amplitude</measure>
    <time_frame>8-11 months</time_frame>
    <description>Measurement of amplitude of electrical potentials that is recorded by surface electrodes over the skin of limb muscles following spinal stimulation or magnetic stimulation of brain over the scalp. The amplitude of the response is reported in micro-volts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Berg Balance Test</measure>
    <time_frame>8-11 months</time_frame>
    <description>Measurement of balance in standing and sitting. The balance score consists of 14 items and is reported in the scale of 56 (each items are score in 0-4).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six-minute walk test</measure>
    <time_frame>8-11 months</time_frame>
    <description>Measurement of walking ability. The distance is reported in meter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ten-minute walk test</measure>
    <time_frame>8-11 months</time_frame>
    <description>Measurement of walking ability. The walking speed is reported in meter per second.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kinetic and kinematic gait analysis using 3D camera system - angle</measure>
    <time_frame>8-11 months</time_frame>
    <description>Measurement of leg function and walking ability. Joint angle is reported in degree angle.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kinetic and kinematic gait analysis using 3D camera system - velocity</measure>
    <time_frame>8-11 months</time_frame>
    <description>Measurement of leg function and walking ability. Velocity is reported in meter per second.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Electromyography recording of LE and trunk muscles</measure>
    <time_frame>8-11 months</time_frame>
    <description>Measurement of muscle and nerve functions. The muscle activities are reported in micro-volts.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spinal Cord Injury - Quality of Life (SCI-QOL) questionnaire</measure>
    <time_frame>8-11 months</time_frame>
    <description>Patient reported quality of life scale. The SCI-QOL consists of 19 item banks, and is reported by T-score comparing the mean of the functional level in the population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spinal Cord Injury - Functional Index (SCI-FI) questionnaire</measure>
    <time_frame>8-11 months</time_frame>
    <description>Patient reported functional scale. The SCI-QOL consists of 10 item banks, and is reported by T-score comparing the mean of the functional level in the population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wartenberg Pendulum Test</measure>
    <time_frame>8-11 months</time_frame>
    <description>The Wartenberg Pendulum Test is a measure of spastic hypertonia. Using computer data for number of oscillations and amplitude, values of the Relaxation index (R1 and R2) are calculated and compared to norms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Walking Index for Spinal Cord Injury II</measure>
    <time_frame>8-11 months</time_frame>
    <description>A functional capacity scale designed to measure improvements in ambulation in persons with spinal cord injury, by evaluating the amount of physical assistance, braces or devices required to walk 10 meters.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurogenic Bladder Symptom Score</measure>
    <time_frame>8-11 months</time_frame>
    <description>24-item questionnaire designed to assess bladder symptoms in patients with neurogenic bladder dysfunction as a result of spinal cord injury, multiple sclerosis, and spinal bifida.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">6</enrollment>
  <condition>Spinal Cord Injuries</condition>
  <condition>Spinal Cord Diseases</condition>
  <condition>Central Nervous System Diseases</condition>
  <condition>Nervous System Diseases</condition>
  <condition>Trauma, Nervous System</condition>
  <condition>Wounds and Injuries</condition>
  <arm_group>
    <arm_group_label>Comparison of transcutaneous &amp; epidural stimulation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Comparison of transcutaneous vs epidural electrical stimulation</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcutaneous spinal stimulation</intervention_name>
    <description>Physical therapy to improve standing and walking</description>
    <arm_group_label>Comparison of transcutaneous &amp; epidural stimulation</arm_group_label>
    <other_name>Physical Therapy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Epidural spinal stimulation</intervention_name>
    <description>Physical therapy to improve standing and walking</description>
    <arm_group_label>Comparison of transcutaneous &amp; epidural stimulation</arm_group_label>
    <other_name>Physical Therapy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. have a spinal cord injury at least one-year duration;

          2. are between 21 and 70 years of age;

          3. have difficulty with leg functions and mobility in activities of daily living (e.g.
             walking, transferring surface to surface, standing);

          4. are candidates for an implanted stimulator;

          5. are willing and able to have surgical implantation of the epidural stimulator for the
             treatment of pain according to the study timeline;

          6. experience chronic pain;

          7. are in stable medical condition without cardiopulmonary disease or frequent autonomic
             dysreflexia that would contraindicate participation in lower extremity rehabilitation
             or testing activities;

          8. are capable of performing simple cued motor tasks;

          9. have the ability to attend 3-5 sessions per week physical therapy sessions and testing
             activities over three months;

         10. have adequate social support to be able to participate in assessment sessions
             occurring between once per week to once per month for up to 9 months;

         11. are volunteering to be involved in this study;

         12. are cleared for gait training by primary physician of the subject;

         13. and have ability to read and speak English

        Exclusion Criteria:

          1. have autoimmune etiology of spinal cord dysfunction/injury;

          2. have a history of additional neurologic disease, such as stroke, MS, traumatic brain
             injury, etc.;

          3. have peripheral neuropathy (diabetic polyneuropathy, entrapment neuropathy, etc.);

          4. have rheumatic diseases (rheumatoid arthritis, systemic lupus erythematosus, etc.);

          5. have significant medical disease; including uncontrolled systemic hypertension with
             values above 170/100 mmHg; cardiac or pulmonary disease; uncorrected coagulation
             abnormalities or need for therapeutic anticoagulation;

          6. have active cancer;

          7. have cardiovascular or musculoskeletal disease or injury that would prevent full
             participation in physical therapy intervention;

          8. have unhealed fracture, contracture, pressure sore, or urinary tract infection or
             other illnesses that might interfere with lower extremity rehabilitation or testing
             activities;

          9. have any condition that would render the patient unable to safely cooperate with the
             study tests as judged by the screening physician;

         10. are pregnant;

         11. are dependent on ventilation support;

         12. have implanted stimulator (e.g. epidural stimulator, vagus nerve stimulator,
             pacemaker, cochlear implant, etc.);

         13. have depression or anxiety based on the Center for Epidemiologic Studies Depression
             Scale (CESD) (score &gt;16/60) and General Anxiety Disorder-7 item Questionnaire (score
             &gt;9/21), respectively.

         14. have alcohol and/or drug abuse;

         15. have cognitive impairment based on Short Portable Mental Status Questionnaire (SPMSQ)
             (score &gt;2/10);

         16. are unable to read and/or comprehend the consent form;

         17. are unable to understand the instructions given as part of the study;

         18. have established osteoporosis and are taking medication for osteoporosis treatment;

         19. have bone mineral density T scores â‰¤ -2.0 in anteroposterior lumbar spine and/or
             proximal femur measured by DEXA (if participants are clear for other criteria and have
             not been examined by DEXA at the screening, we will ask participants to undergo DEXA
             to reveal any risk of weight bearing activity);

         20. have a low-energy fracture history before or after spinal cord injury;

         21. have a history of orthopedic surgery in lower extremities that may be a confounding
             factor for interpretation of the results (such as tendon transfer, tendon or muscle
             lengthening for spasticity management, etc.);

         22. have fixed lower extremity joint contractures;

         23. are taller than 80 inches and/or weighs more than 350 pounds (due to the limitation of
             the experimental equipment such as the body weight support system);

         24. lack the ability to fully comprehend and/or perform study procedures in the
             investigator's opinion/judgement
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rajiv Saigal, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Washington</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Soshi Samejima, DPT, MS</last_name>
    <phone>206-221-8961</phone>
    <email>soshis@uw.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Monica Smersh</last_name>
    <phone>206-543-6995</phone>
    <email>msmersh@uw.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Soshi Samejima, DPT, MS</last_name>
      <phone>206-221-8961</phone>
      <email>soshis@uw.edu</email>
    </contact>
    <contact_backup>
      <last_name>Rajiv Saigal, MD, PhD</last_name>
      <email>rsaigal@uw.edu</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>July 31, 2019</study_first_submitted>
  <study_first_submitted_qc>July 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">August 2, 2019</study_first_posted>
  <last_update_submitted>August 13, 2019</last_update_submitted>
  <last_update_submitted_qc>August 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Washington</investigator_affiliation>
    <investigator_full_name>Rajiv Saigal</investigator_full_name>
    <investigator_title>Assistant Professor, School of Medicine: Neurological Surgery</investigator_title>
  </responsible_party>
  <keyword>transcutaneous spinal stimulation</keyword>
  <keyword>epidural spinal stimulation</keyword>
  <keyword>physical therapy</keyword>
  <keyword>lower extremity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Cord Injuries</mesh_term>
    <mesh_term>Central Nervous System Diseases</mesh_term>
    <mesh_term>Spinal Cord Diseases</mesh_term>
    <mesh_term>Trauma, Nervous System</mesh_term>
    <mesh_term>Wounds and Injuries</mesh_term>
    <mesh_term>Nervous System Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

